Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene - PubMed (original) (raw)
Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene
K Wiechen et al. Am J Pathol. 2001 Nov.
Abstract
To identify novel markers differentially expressed in ovarian cancer versus normal ovary, we hybridized microarrays with cDNAs derived from normal human ovaries and advanced stage ovarian carcinomas. This analysis revealed down-regulation of the caveolin-1 gene (CAV1) in ovarian carcinoma samples. Suppression of CAV1 in ovarian carcinomas was confirmed using a tumor tissue array consisting of 68 cDNA pools from different matched human tumor and normal tissues. Immunohistochemistry demonstrated expression of caveolin-1 in normal and benign ovarian epithelial cells, but loss of expression in serous ovarian carcinomas. In low-grade carcinomas, redistribution of caveolin-1 from a membrane-associated pattern observed in normal epithelium to a cytoplasmic localization pattern was observed. No expression of caveolin-1 was detectable in four of six ovarian carcinoma cell lines investigated. In SKOV-3 and ES-2 carcinoma cells, which express high levels of the caveolin-1 protein, phosphorylation of the 22-kd caveolin-1 isoform was detected. Inhibition of both DNA methylation and histone deacetylation using 5-aza-2'deoxycytidine and Trichostatin A, respectively, relieves down-regulation of caveolin-1 in OAW42 and OVCAR-3 cells which is in part mediated by direct regulation at the mRNA level. Expression of CAV1 in the ovarian carcinoma cell line OVCAR-3, resulted in suppression of tumor cell survival in vitro, suggesting that the CAV1 gene is likely to act as a tumor suppressor gene in human ovarian epithelium.
Figures
Figure 1.
Expression analysis of CAV1 using the matched tumor/normal array. a: Organization of the cDNA samples derived from tumor and normal tissue of individual patients on the array. N**,** normal; T, tumor. Numbers 1 to 9 identify cDNAs derived from the following cell lines: 1, HeLa; 2, Daudi; 3, K562; 4, HL60; 5, G361; 6, A594; 7, Molt4; 8, SW480; 9, Raji. b: Hybridization results obtained with the CAV1 probe. The filters used contain three ovary samples (serous type adenocarcinomas) indicated in the figure by N (normal) and T (tumor) and numbers 1 to 3. c: Relative CAV1 expression levels as obtained by phosphoimage analysis in the three ovary-derived cDNA pairs are shown in the table.
Figure 2.
Western blot and immunohistochemical analysis of caveolin-1 expression in human ovarian carcinoma cells. a: In human ovarian surface epithelial cells (HOSE), in ES-2 and SKOV-3 human ovarian carcinoma cells the α (22 kd) and β-isoforms (24 kd) of caveolin-1 are present, no expression is detected in MDAH2774, CAOV-3, OCVAR-3, and OAW42. Both isoforms are also present in protein preparation of two serous ovarian adenomas (Ad1, Ad2). b: The use of a phospho-caveolin-1-specific antibody shows Tyr-14 phosphorylation of the caveolin-1 α-isoform in tumor cell lines ES-2 and SKOV-3. A lysate from RSV-3T3 mouse fibroblasts expressing pp60src was used as a positive control. Blots were stripped and reprobed with an antibody against cytoplasmic actin to control for equal loading. c: Immunohistochemical analysis of caveolin-1 shows expression in the surface epithelium and in the underlying stroma of normal ovary. d: A similar staining is evident in the epithelial lining of a serous adenoma, whereas loss of the membrane-associated localization and down-regulation can be observed in a grade 1 serous carcinoma as depicted by the arrow (e). f: Complete loss of caveolin-1 expression from the epithelial cells is observed in a grade 3 serous carcinoma. Positive staining of blood vessel endothelial cells serves as an internal positive control.
Figure 3.
Caveolin-1 expression can be reconstituted in OAW42 (a) and OVCAR-3 (b) ovarian carcinoma cells by treatment with the DNA methylation inhibitor 5-aza-2′deoxycytidine (5-aza) and the histone deacetylase inhibitor TSA. Western blot analysis was performed with extracts prepared from untreated cells (lane 1), 72 hours after incubation with 50 μmol/L PD98059 (lane 2), with 10 μmol/L LY294002 (lane 3), with 5 μmol/L 5-aza-2′deoxycytidine (lane 4), with 25 ng/ml TSA (lane 5), with a combination of 5-aza-2′deoxycytidine and TSA (5 μmol/L, 25 ng/ml; lane 6) with the solvents ethanol (E, lane 7) or dimethyl sulfoxide (D, lane 8). c: Northern blot analysis of CAV1 mRNA expression after incubation of OVCAR-3 and OAW42 cells with 25 ng/ml TSA or 5 μmol/L of 5-aza-2′deoxycytidine. Cells were incubated for 72 hours in standard medium (−), with the inhibitors or the solvent ethanol before RNA preparation and hybridization with a _CAV1-_specific probe. 28S and 18S ribosomal RNA are shown as a loading control.
Figure 4.
A: Colony formation assay demonstrating a strong reduction of survival in OVCAR-3 cells by expression of caveolin-1. OVCAR-3 cells were transfected with either the _caveolin-1-_expressing vector (pLNHX-cav) or the empty vector (pLNHX). Cells were selected in 0.5 mg/ml of G418 until colonies were visible. After fixation and staining, colonies were counted and values are displayed as colonies/flask (75 cm2). The mean range and SD of four independent experiments is shown. B: High expression of caveolin-1 protein in OVCAR-3 cells after transient transfection of pc-CAV-V5. Cells were either transfected with pc-CAV-V5, the empty plasmid pc-V5 or left untransfected (−) before preparation of protein extracts. The V5-epitope-tagged caveolin-1 expression construct encodes a protein of a ∼32 kd. SKOV-3 cells were used as a positive control and actin was used as a loading control. C: Colony formation assay using the pc-CAV-V5 construct or the empty plasmid pc-V5 in OVCAR-3 cells. Zeocin-resistant colonies were selected for 2 weeks, fixed, and stained. D: Overexpression of pc-CAV-V5 increases apoptosis in OVCAR-3 cells. OVCAR-3 cells were transiently transfected with pc-CAV-V5 (caveolin-1) or the empty pc-V5 (vector). DNA fragmentation assay (TUNEL) was performed 48 hours later and nuclei were stained using diamidinophenylindole (DAPI). Arrows show TUNEL-stained cells, indicative of apoptosis.
Similar articles
- Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression.
Bagnoli M, Tomassetti A, Figini M, Flati S, Dolo V, Canevari S, Miotti S. Bagnoli M, et al. Oncogene. 2000 Sep 28;19(41):4754-63. doi: 10.1038/sj.onc.1203839. Oncogene. 2000. PMID: 11032026 - Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer.
Sunaga N, Miyajima K, Suzuki M, Sato M, White MA, Ramirez RD, Shay JW, Gazdar AF, Minna JD. Sunaga N, et al. Cancer Res. 2004 Jun 15;64(12):4277-85. doi: 10.1158/0008-5472.CAN-03-3941. Cancer Res. 2004. PMID: 15205342 - Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
Feng W, Marquez RT, Lu Z, Liu J, Lu KH, Issa JP, Fishman DM, Yu Y, Bast RC Jr. Feng W, et al. Cancer. 2008 Apr 1;112(7):1489-502. doi: 10.1002/cncr.23323. Cancer. 2008. PMID: 18286529 - [Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray].
Konno R. Konno R. Hum Cell. 2001 Dec;14(4):261-6. Hum Cell. 2001. PMID: 11925926 Review. Japanese. - A step further in understanding the biology of the folate receptor in ovarian carcinoma.
Bagnoli M, Canevari S, Figini M, Mezzanzanica D, Raspagliesi F, Tomassetti A, Miotti S. Bagnoli M, et al. Gynecol Oncol. 2003 Jan;88(1 Pt 2):S140-4. doi: 10.1006/gyno.2002.6705. Gynecol Oncol. 2003. PMID: 12586106 Review. No abstract available.
Cited by
- Unraveling the Cave: A Seventy-Year Journey into the Caveolar Network, Cellular Signaling, and Human Disease.
D'Alessio A. D'Alessio A. Cells. 2023 Nov 22;12(23):2680. doi: 10.3390/cells12232680. Cells. 2023. PMID: 38067108 Free PMC article. Review. - The Structural Proteins of Membrane Rafts, Caveolins and Flotillins, in Lung Cancer: More Than Just Scaffold Elements.
Saldaña-Villa AK, Lara-Lemus R. Saldaña-Villa AK, et al. Int J Med Sci. 2023 Oct 2;20(13):1662-1670. doi: 10.7150/ijms.87836. eCollection 2023. Int J Med Sci. 2023. PMID: 37928877 Free PMC article. Review. - Caveolin-1 mediates the utilization of extracellular proteins for survival in refractory gastric cancer.
Hwang N, Yoon BK, Chun KH, Kim H, Lee Y, Kim JW, Jeon H, Kim TH, Kim MY, Fang S, Cheong JH, Kim JW. Hwang N, et al. Exp Mol Med. 2023 Nov;55(11):2461-2472. doi: 10.1038/s12276-023-01109-7. Epub 2023 Nov 2. Exp Mol Med. 2023. PMID: 37919422 Free PMC article. - The discovery of promising candidate biomarkers in kidney renal clear cell carcinoma: evidence from the in-depth analysis of high-throughput data.
Li X, Li M, Zhao T, Zhang J. Li X, et al. Am J Cancer Res. 2023 Sep 15;13(9):4288-4304. eCollection 2023. Am J Cancer Res. 2023. PMID: 37818073 Free PMC article. - PET and Optical Imaging of Caveolin-1 in Gastric Tumors.
Surendra Panikar S, Shmuel S, Lewis JS, Pereira PMR. Surendra Panikar S, et al. ACS Omega. 2023 Sep 15;8(39):35884-35892. doi: 10.1021/acsomega.3c03614. eCollection 2023 Oct 3. ACS Omega. 2023. PMID: 37810678 Free PMC article.
References
- Vogelstein B, Kinzler KW: The multistep nature of cancer. Trends Genet 1993, 9:138-141 - PubMed
- Bos JL: Ras oncogenes in human cancer: a review. Cancer Res 1989, 49:4682-4689 - PubMed
- Weinberg RA: Tumor suppressor genes. Science 1991, 254:1138-1146 - PubMed
- Merlo A, Herman JG: DNA methylation and inactivation of tumor suppressor genes. Müller HJ Scott RJ Weber W eds. Hereditary Cancer. 1996, :pp 152-160 Karger, Basel
- Anderson RG: The caveolae membrane system. Annu Rev Biochem 1998, 67:199-225 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical